PioneerIP, an innovative leader in AI-powered automation for patent infringement search, is excited to announce that it has successfully raised $400,000 in its latest funding round. This significant capital infusion marks a pivotal moment for the company as it continues to redefine how intellectual property conflicts are identified and mitigated through cutting-edge technology. With this funding, PioneerIP is poised to accelerate the development of its advanced algorithms and enhance its data analytics capabilities, ensuring that the evaluation of patent infringement becomes not only faster but also more accurate. The investment will be strategically allocated towards expanding the company’s research and development initiatives, enabling the integration of more sophisticated machine learning models that can predict potential infringement scenarios with greater precision. Additionally, the funds will support the expansion of PioneerIP’s engineering team, further strengthening its operational backbone and opening up new avenues for strategic partnerships with industry leaders. As PioneerIP sets its sights on scaling its solutions for a broader range of applications, this capital will also be crucial in enhancing its market presence and broadening its impact within the legal and technology sectors. By continually refining its automation processes, PioneerIP is committed to reducing the administrative and financial burdens often associated with patent litigation, ultimately empowering businesses to focus on innovation while safeguarding their intellectual assets. This funding milestone not only underscores investor confidence in the transformative potential of AI within the patent landscape but also reinforces PioneerIP’s mission to provide a smarter, more efficient approach to navigating patent infringement challenges in an increasingly competitive market.
PioneerIP Secures $400K Pre-Seed Investment to Revolutionize Patent Infringement Search with AI
Get the full PioneerIP company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Texas Automated Robotics Systems, LLC
Tars Robotics, based in Houston Texas, strives to equip manufacturers with the highest quality robotic automation equipment at the most economical value in the industry. Our goal is to enable as many American manufacturers with the ability to compete in the global injection molding industry. We continue to support the initiative to re-shore products from all industries back to the United States. We offer a wide and unique line of robotic arms for machines ranging from 30 tons to 4,000 tons while providing the best solutions no matter how intelligible or complex. With our customer’s need in mind, our product lines include a diverse series of robots designed for sprue and parts removal, insert molding, de-gating, in-mold labeling, and parts stacking.
$513.0M Seed
today
Viseur AI - Digital Pathology Platform
Viseur AI is a digital pathology and medical imaging platform built to become the operating system of AI-enabled diagnostics. We unify Pathology Information Management (PIMS), Digital Pathology / WSI viewing (IMS), AI model deployment and governance, and enterprise-grade integrations into a single, vendor-agnostic platform designed for real clinical workflows. Healthcare systems and diagnostic labs struggle with fragmented pathology workflows, scanner-locked software, and AI solutions that rarely reach routine clinical use. Viseur AI addresses this by delivering an end-to-end digital pathology platform from specimen to report, combining enterprise-grade WSI viewing, AI model deployment and management, on-prem or hybrid architectures aligned with data privacy and regulatory requirements, and deep LIS, HIS, and PACS integrations that enable standardised and scalable operations across multiple sites. Certified under ISO 13485, ISO 27001, and ISO/IEC 15504-SPICE, Viseur AI creates a foundation for clear and compatible AI in healthcare.
$350.0K Seed
today
Imperagen
Imperagen is advancing enzyme engineering through an integrated, AI-driven platform that enables faster and more precise development of high-performance enzymes. By combining advanced computational modeling with automated lab testing, we help companies improve production processes while reducing cost, time, and environmental impact. Founded by researchers from the Manchester Institute of Biotechnology, Imperagen brings together expertise in physics-based simulation, machine learning, and high-throughput experimentation. Our closed-loop platform continuously learns from real-world data, allowing us to design, test, and refine enzymes with greater accuracy and efficiency than traditional approaches . We take a problem-specific approach, tailoring each solution to the unique requirements of a given enzyme, reaction, and application. We work with organizations across pharma, life sciences, chemicals, food, and consumer goods to solve complex enzyme engineering challenges. Our approach helps reduce development risk, shorten timelines, and support the shift toward more sustainable, enzyme-based manufacturing. Get in touch to learn more about our innovative platform and discover how we can quickly transform your enzyme needs into market-ready solutions.
$6.4M Seed
today
Omni
Omni is an AI analytics platform that empowers everyone—regardless of technical ability—to easily analyze data using AI, spreadsheets, SQL, or point-and-click interfaces. It is built on a semantic layer that makes sure every insight is accurate and dependable. Beyond powering internal analytics, Omni makes it easy for businesses to offer highly customizable in-product analytics to their customers.
$120.0M Series c
today
Moment
The largest RIAs, broker dealers, and private banks trust Moment to power investment management for their traders and advisors. Founded by former fixed income quants from Citadel and Jane Street and backed by over $50M in funding from the world’s leading investors, Moment has developed the first operating system built specifically for wealth management. With Moment’s solution, advisors can build personalized portfolios in seconds, traders can set rules to automatically execute orders at all of the major trading venues, and portfolio managers can automate reinvestment, rebalancing, and compliance monitoring. Moment is headquartered in the Financial District of New York City. Learn more below and follow the team’s rapid growth here on LinkedIn.
$78.0M Series c
today
Other recent Pre-seed rounds
Companies that recently closed a Pre-seed round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Synakis Canada | Pre-seed | $2.6M | today |
| 2 |  shatterdome energy India | Pre-seed | $3.5M | today |
| 3 |  Meta Fashion India | Pre-seed | $400.0K | 1d ago |
| 4 |  AVIAN Switzerland | Pre-seed | $2.6M | 2d ago |
| 5 |  EvoTouch | Pre-seed | $332.8K | 2d ago |